All News about Foghorn Therapeutics Inc
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
Foghorn Therapeutics Announces Chief Medical Officer Succession
August 08, 2023
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
What 5 Analyst Ratings Have To Say About Foghorn Therapeutics
August 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Foghorn Therapeutics
June 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/30/image19_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/29/image45.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Foghorn Therapeutics's Future
April 25, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Foghorn Therapeutics
March 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/28/fhtx.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/crude_oil_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/ideaya_biosciences_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/image34_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/fhtx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_7701.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 24, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
Foghorn Therapeutics Provides an Update on FHD-609
April 24, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
![](https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.